Netarsudil-associated reticular corneal epithelial edema

Jennifer A Tran1, Ula V Jurkunas2, Jia Yin2

  • 1Massachusetts Eye and Ear, Harvard Medical School, Department of Ophthalmology, 243 Charles Street, Boston, MA, 02114, USA.

Summary

Topical netarsudil, a Rho-kinase inhibitor, can cause reversible reticular corneal epithelial edema in patients, even those with pre-existing corneal conditions. This condition resolved after discontinuing netarsudil treatment.